Suchergebnisse - "Pasello, Giulia"

PubPharm (144)

1

The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients : the challenge is open for new therapeutic strategies

enthalten in: Critical reviews in oncology/hematology | 2024

von Ferro, A. | Marinato, G. | Mulargiu, C. | +4

2

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Leonetti, A. | Perrone, F. | Puntoni, M. | +43

3

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy : Nevermore without the Pathology Report

enthalten in: Journal of personalized medicine | 2024

von Rossi, G. | Righi, L. | Barbisan, F. | +14

4

The biomarkers ATLAS : An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Malapelle, U. | Passiglia, F. | Pepe, F. | +16

5

Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer : Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World

enthalten in: The oncologist | 2024

von Pasello, G. | Lorenzi, M. | Scattolin, D. | +16

6

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

enthalten in: Journal of translational medicine | 2024

von Pasello, G. | Fabricio, A. | Del Bianco, P. | +15

7

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

enthalten in: Journal of translational medicine | 2024

von Pasello, G. | Fabricio, A. | Del Bianco, P. | +15

8

Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy : Preanalytical and analytical considerations

enthalten in: The International journal of biological markers | 2024

von Cappelletto, E. | Fasiolo, L. | Salizzato, V. | +8

9

Nivolumab in pretreated pleural mesothelioma : Results from an observational real-world study of patients treated within the AIFA 5% Fund

enthalten in: Tumori | 2024

von Cerbone, L. | Delfanti, S. | Crivellari, S. | +18

10

Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer : a multicentric analysis

enthalten in: Frontiers in immunology | 2024

von Bonanno, L. | Calvetti, L. | Dal Maso, A. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]